Within the MaTissE project three prototypes of magnetic tissue bioreactors, stretcher, cyclic stimulator, and aligner, were produced and successfully tested, either with skeletal muscle precursors to force the stretched muscle geometry, or with embryonic stem cells with the demonstration of a remote magnetic control of stem cells differentiation, or with cardiomyocytes to align them in a 3D gel. We also tested different protocols to allow a better cartilage differentiation, implemented magnetic cartilage tissue engineering in scaffolds, and explored the role of extracellular vesicles in this differentiation. Concerning the nanofate of nanoparticles, we have implemented new methods to track the long-term intracellular and tissular fate of nanoparticles, and we have demonstrated a massive intracellular biodegradation, which could be prevented by a gold shell or a polymeric coating. We also demonstrated that a bench-top size magnetic sensor could be used to monitor in operando, in situ, on living environment, the magnetism of cells or engineered tissues. Remarkably, all these magnetic measurements at the tissue scale allowed to evidence that nanoparticles can have a true intracellular destruction/(re)synthesis cycle and offered the first experimental evidence that magnetic nanoparticles can be synthesized endogenously in human stem cells. Finally, we have also exported the innovative methodologies introduced to other metallic nanoparticles, embedded in a tissue construct.